Jesse Reeves-Garcia
Pediatric Gastroenterology · Miami, FLNPI 1134150477
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 169 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 16.2% — the pattern of someone who eats at a lot of different presentations.
Across 169 payments — averaging $28.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$794
- Sanofi$609
- Takeda Pharmaceuticals U.S.A., Inc.$458
- Johnson & Johnson$455
- Ipsen Biopharmaceuticals, Inc$454
- Janssen Scientific Affairs, LLC$398
- plus $2K from 20 others
What the payments were for
- Food & beverage$4,891100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 28 | $794 |
| Sanofi | 17 | $609 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $458 |
| Johnson & Johnson | 20 | $455 |
| Ipsen Biopharmaceuticals, Inc | 21 | $454 |
| Janssen Scientific Affairs, LLC | 5 | $398 |
| Nestle Healthcare Nutrition Inc. | 18 | $307 |
| Medtronic | 2 | $302 |
| Regeneron Healthcare Solutions, Inc. | 8 | $283 |
| Mirum Pharmaceuticals, Inc. | 6 | $167 |
| Albireo Pharma, Inc. | 2 | $145 |
| QOL Medical, LLC | 6 | $104 |
| AstraZeneca | 1 | $57 |
| Phadia US Inc. | 3 | $49 |
| Travere Therapeutics, Inc. | 2 | $48 |
| Alfasigma USA, Inc. | 2 | $44 |
| Aimmune Therapeutics, Inc. | 2 | $34 |
| Amryt Pharma Holdings Ltd | 2 | $32 |
| Mauna Kea Technologies, Inc. | 1 | $23 |
| Celltrion USA Inc. | 1 | $22 |
| Ironwood Pharmaceuticals, Inc | 1 | $20 |
| Biogen | 1 | $20 |
| Boehringer Ingelheim | 1 | $19 |
| Pfizer | 1 | $18 |
| Organon | 1 | $14 |
| Olympus America Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,891 in reported general payments places this provider in the 75th percentile of 128 pediatric gastroenterology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Glycopyrrolate | 14 | $1,668 |
Paid to pharmacies, not to this prescriber.
Other pediatric gastroenterology in Miami
- Alisa Muniz CrimMiami$50K
- Erick HernandezMiami$12K
- Miguel SapsMiami$9K
- Jennifer GarciaMiami$6K
- Lina FelipezMiami$5K
- Richard ArboledaMiami$5K
- Luis Caicedo OquendoMiami$5K
- Oscar Loret de MolaMiami$4K
- Laura IrastorzaMiami$4K
- Robert GomaraMiami$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.